VRNA
Verona Pharma
VRNA
VRNA
291 hedge funds and large institutions have $7.18B invested in Verona Pharma in 2025 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 80 increasing their positions, 109 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
291
Holders Change
+33
Holders Change %
+12.79%
% of All Funds
3.9%
Holding in Top 10
29
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.57%
% of All Funds
0.39%
New
70
Increased
80
Reduced
109
Closed
33
Calls
$102M
Puts
$328M
Net Calls
-$226M
Net Calls Change
-$152M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$149M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$99.6M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$87.3M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$82.8M |
| 5 |
D.E. Shaw & Co
New York
|
+$75.8M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$136M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$119M |
| 3 |
PA
Perceptive Advisors
New York
|
-$99.9M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$77M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$47.4M |
